annual shareholders equity:
$3.31B+$2.07B(+166.50%)Summary
- As of today (July 3, 2025), PCVX annual stockholders equity is $3.31 billion, with the most recent change of +$2.07 billion (+166.50%) on December 31, 2024.
- During the last 3 years, PCVX annual shareholders equity has risen by +$3.02 billion (+1063.95%).
- PCVX annual shareholders equity is now at all-time high.
Performance
PCVX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$3.20B-$105.79M(-3.20%)Summary
- As of today (July 3, 2025), PCVX quarterly stockholders equity is $3.20 billion, with the most recent change of -$105.79 million (-3.20%) on March 31, 2025.
- Over the past year, PCVX quarterly shareholders equity has increased by +$1.22 billion (+61.29%).
- PCVX quarterly shareholders equity is now -6.37% below its all-time high of $3.42 billion, reached on September 30, 2024.
Performance
PCVX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PCVX Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +166.5% | +61.3% |
3 y3 years | +1064.0% | +790.0% |
5 y5 years | +3207.8% | +2221.4% |
PCVX Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1064.0% | -6.4% | +790.6% |
5 y | 5-year | at high | +3207.8% | -6.4% | +1026.7% |
alltime | all time | at high | +3207.8% | -6.4% | +3108.3% |
PCVX Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $3.20B(-3.2%) |
Dec 2024 | $3.31B(+166.5%) | $3.31B(-3.3%) |
Sep 2024 | - | $3.42B(+72.1%) |
Jun 2024 | - | $1.99B(+0.1%) |
Mar 2024 | - | $1.98B(+59.9%) |
Dec 2023 | $1.24B(+30.1%) | $1.24B(-11.6%) |
Sep 2023 | - | $1.40B(-2.1%) |
Jun 2023 | - | $1.43B(+51.7%) |
Mar 2023 | - | $944.77M(-0.9%) |
Dec 2022 | $953.61M | $953.61M(+165.4%) |
Sep 2022 | - | $359.31M(-2.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $366.50M(+1.9%) |
Mar 2022 | - | $359.54M(+26.6%) |
Dec 2021 | $284.02M(-17.9%) | $284.02M(-7.2%) |
Sep 2021 | - | $305.96M(-3.5%) |
Jun 2021 | - | $317.02M(-3.0%) |
Mar 2021 | - | $326.94M(-5.5%) |
Dec 2020 | $345.84M(-425.1%) | $345.84M(-5.0%) |
Sep 2020 | - | $364.07M(-5.0%) |
Jun 2020 | - | $383.21M(+178.0%) |
Mar 2020 | - | $137.85M(-229.6%) |
Dec 2019 | -$106.37M(+84.3%) | -$106.37M |
Dec 2018 | -$57.73M | - |
FAQ
- What is Vaxcyte annual stockholders equity?
- What is the all time high annual shareholders equity for Vaxcyte?
- What is Vaxcyte annual shareholders equity year-on-year change?
- What is Vaxcyte quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vaxcyte?
- What is Vaxcyte quarterly shareholders equity year-on-year change?
What is Vaxcyte annual stockholders equity?
The current annual shareholders equity of PCVX is $3.31B
What is the all time high annual shareholders equity for Vaxcyte?
Vaxcyte all-time high annual stockholders equity is $3.31B
What is Vaxcyte annual shareholders equity year-on-year change?
Over the past year, PCVX annual stockholders equity has changed by +$2.07B (+166.50%)
What is Vaxcyte quarterly stockholders equity?
The current quarterly shareholders equity of PCVX is $3.20B
What is the all time high quarterly shareholders equity for Vaxcyte?
Vaxcyte all-time high quarterly stockholders equity is $3.42B
What is Vaxcyte quarterly shareholders equity year-on-year change?
Over the past year, PCVX quarterly stockholders equity has changed by +$1.22B (+61.29%)